JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8198 P 22077

Summary: USP7/(DUB)USP47 inhibitor

insoluble in H2O; insoluble in EtOH; ≥14.6 mg/mL
A2601 Aclacinomycin A

4 Citation

Target: Topoisomerases

Summary: Topoisomerase I and II inhibitor

Soluble in DMSO
A4022 BMS-708163 (Avagacestat)

Summary: γ-secretase inhibitor

insoluble in H2O; ≥177.6 mg/mL
A4083 Rocilinostat (ACY-1215)

5 Citation

Target: Histone Deacetylases (HDACs)

Summary: Selective HDAC6 inhibitor

≥21.675 mg/mL
A4084 Vorinostat (SAHA, MK0683)

22 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
A4060 Geldanamycin

2 Citation

Summary: Hsp90 inhibitor,potent and specific

insoluble in EtOH; insoluble in H2O; ≥16.9 mg/mL
A4154 Olaparib (AZD2281, Ku-0059436)

37 Citation

Summary: PARP-1/2 inhibitor

≥21.72 mg/mL
A4112 Barasertib (AZD1152-HQPA)

6 Citation

Target: Aurora Kinases

Summary: Aurora Kinase B inhibitor, Potent and selective

≥25.4 mg/mL
A4036 Sitagliptin phosphate monohydrate

10 Citation

Target: DPP-4

Summary: Potent DPP-4 inhibitor

≥23.8 mg/mL
A4230 NSC 66811

Summary: MDM2 inhibitor

≥34 mg/mL